Esther Calonge

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 386 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Quinoline-based compounds as modulators of HIV transcription through NF-κB and Sp1 inhibition

Luis M. Bedoya, Marı́a José Abad, Esther Calonge et al. · Antiviral Research · 2010 · 65 citations

Life Sciences, Medicinal Chemistry, Pharmacology +15

CXCL12 gene expression is upregulated by hypoxia and growth arrest but not by inflammatory cytokines in rheumatoid synovial fibroblasts

Begoña Santiago, Esther Calonge, Irene Gutiérrez‐Cañas et al. · Cytokine · 2010 · 57 citations · Full text

Life Sciences, Cell Biology, Immunology +11

H-ras Immunohistochemical Expression and Molecular Analysis of Urinary Bladder Lesions in Grazing Adult Cattle Exposed to Bracken Fern

David Sardón, Ignacio de la Fuente, Esther Calonge et al. · Journal of Comparative Pathology · 2005 · 33 citations

Veterinary Medicine, Animal Sciences, Veterinary Pathology +4

SDF-1/CXCL12 Production by Mature Dendritic Cells Inhibits the Propagation of X4-Tropic HIV-1 Isolates at the Dendritic Cell-T-Cell Infectious Synapse

Núria Gonzàlez, Mercedes Bermejo, Esther Calonge et al. · Journal of Virology · 2010 · 26 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15